Experts to present latest research on aging and longevity at the 8th Aging Research & Drug Discovery Meeting
Reviewed by Emily Henderson, B.Sc.Apr 22 2021
Scheibye-Knudsen Lab, University of Copenhagen and Deep Longevity are excited to reveal the speakers for the 8th Aging Research & Drug Discovery Meeting, the largest scientific academic, and industry conference that will transpire on August 31 – September 3, 2021, on-site at the Ceremonial Hall, University of Copenhagen, and online.
According to the United Nations, the proportion of people aged over 65 now outnumber children younger than 5. The enormous growth in the elderly population is posing a significant healthcare challenge to societies worldwide most evident from the ongoing Covid-19 pandemic.
New sweeping interventions for reducing age-associated morbidities and frailty will undoubtedly be a key to reduce the health- and socioeconomic challenges that come with an aging society. This year we have an incredibly exciting program with global thought-leaders sharing their latest insights into aging and how we target the aging process ensuring everyone lives a healthier and longer life.
With the pandemic that has raged across the world slowly becoming manageable due to vaccines we decided to host the ARDD2021 conference in person at the University of Copenhagen. We are extremely excited about the program and the possibility of meeting friends and colleagues outside of zoom. This year we are maintaining our focus on young scientists who will be the future of our field and we have a large amount of speaker slots for these rising stars."
Morten Scheibye-Knudsen, MD, Ph.D., University of Copenhagen
"The 8th ARDD Meeting 2021 organized by the Scheibye-Knudsen lab will be supported by the top leaders in aging research. It will have a fresh program featuring some of the most prominent scientists and industry players in AI, drug discovery, ageing, and longevity research covering the theory, applications and convergence of these exciting areas." said Alex Zhavoronkov, Ph.D Founder, and CEO of Insilico Medicine.